S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease|
|Shareholder Alert: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of PLX Technology, INC. -- PLXT|
|Avago Technologies Limited Successfully Completes Tender Offer for Shares of PLX Technology, Inc. -- Acquisition to Close Today|
|UPDATE: Cash-rich spending spree is sign of a growing tech bubble (2014/8/7)|
|United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension|
|Avago Technologies Limited Announces Third Quarter Fiscal Year 2014 Financial Results|
|Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing|
|Israel's Ministry of Health Approves Pluristem's Commercial-Scale 3D Cell Manufacturing Process Used at Its New Haifa Facility|
|Coverage Initiation Report Focuses on Pluristem Therapeutics|
|Avago Advanced SAS Storage Technology Powers Over 250 Next-Generation Server Models Using Latest Intel(R) Xeon(R) Processors|
Click above to view more mutual fund data and stats for plx - Protalix BioTherapeutics Inc.